perillyl alcohol has been researched along with Neoplasms in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| da Silva, CEH; de Andrade, SF; Gosmann, G | 1 |
| Chen, TC; Hofman, FM; Myint, PT; Nouri Nigjeh, E; Schönthal, AH; Wang, W; Yu, J; Zandi, E | 1 |
| Adu-Frimpong, M; Mukhtar, YM; Xu, X; Yu, J | 1 |
| Albuquerque Júnior, RL; Amaral, RG; Andrade, LN; Carvalho, AA; da Silva, TK; de Sousa, DP; do Nascimento, LG; Dória, GA; Fonseca, CS; Thomazzi, SM | 1 |
| Azzoli, CG; Kris, MG; Krug, LM; Miller, VA; Ng, KK; Riedel, ER; Spriggs, DR; Tong, WP | 1 |
| Alberti, D; Arzoomanin, R; Bailey, H; Binger, K; Black, S; Dubey, S; Ellingen, S; Feierabend, C; Gould, M; Marnocha, R; Morgan-Meadows, S; Pomplun, M; Tutsch, K; Volkman, J; Wilding, G | 1 |
| Alberti, D; Arzoomanian, RZ; Bailey, HH; Feierabend, C; Hohl, RJ; Holstein, SA; Lewis, KA; Marnocha, R; Simon, K; Stewart, J; Tutsch, KD; Wilding, G | 1 |
| Buechler, RD; Hentosh, P; Peffley, DM; Sharma, C | 1 |
| Hohl, RJ; Lewis, KA | 1 |
| Alberti, D; Arzoomanian, RZ; Bailey, HH; Feierabend, C; Gould, MN; Pomplun, M; Ripple, GH; Stewart, JA; Tutsch, KD; Wilding, G | 1 |
| Belanger, JT | 1 |
| Alberti, D; Arzoomanian, RZ; Bailey, HH; Binger, K; Feierabend, C; Gould, MN; Marnocha, R; Pomplun, M; Ripple, GH; Simon, K; Tutsch, KD; Wahamaki, A; Wilding, G | 1 |
| Adams, A; Gallo, JM; Halberr, T; Hudes, GR; Langer, CJ; Litwin, S; McCauley, RA; Qian, M; Ranganathan, S; Szarka, CE; Weiner, LM; Yeslow, G | 1 |
4 review(s) available for perillyl alcohol and Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
Limonene and Perillyl Alcohol Derivatives: Synthesis and Anticancer Activity.
Topics: Antineoplastic Agents; Carbohydrates; Cell Survival; Humans; Limonene; Monoterpenes; Neoplasms; Structure-Activity Relationship; Thiosemicarbazones | 2021 |
Biochemical significance of limonene and its metabolites: future prospects for designing and developing highly potent anticancer drugs.
Topics: Cyclohexenes; Drug Design; Humans; Limonene; Methyl Ethers; Monoterpenes; Neoplasms | 2018 |
Perillyl alcohol: applications in oncology.
Topics: Animals; Antineoplastic Agents; Clinical Trials, Phase I as Topic; Humans; Monoterpenes; Neoplasms; Terpenes | 1998 |
6 trial(s) available for perillyl alcohol and Neoplasms
| Article | Year |
|---|---|
A phase I trial of perillyl alcohol in patients with advanced solid tumors.
Topics: Antineoplastic Agents; Female; Humans; Male; Middle Aged; Monoterpenes; Nausea; Neoplasms; Proto-Oncogene Mas; Surveys and Questionnaires; Vomiting | 2003 |
Phase I trial of perillyl alcohol administered four times daily continuously.
Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Male; Middle Aged; Monoterpenes; Neoplasms | 2003 |
A phase I trial of perillyl alcohol administered four times daily for 14 days out of 28 days.
Topics: Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Monoterpenes; Neoplasms | 2004 |
Phase I clinical trial of perillyl alcohol administered daily.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Digestive System; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Monoterpenes; Neoplasms; Neutropenia; Terpenes | 1998 |
Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Area Under Curve; Biotransformation; Drug Administration Schedule; Female; Half-Life; Humans; Male; Middle Aged; Monoterpenes; Neoplasms; Terpenes | 2000 |
Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Cyclohexenes; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Monoterpenes; Neoplasms; Proto-Oncogene Proteins p21(ras); Terpenes; Tumor Cells, Cultured | 2000 |
4 other study(ies) available for perillyl alcohol and Neoplasms
| Article | Year |
|---|---|
A perillyl alcohol-conjugated analog of 3-bromopyruvate without cellular uptake dependency on monocarboxylate transporter 1 and with activity in 3-BP-resistant tumor cells.
Topics: Adenosine Triphosphate; Alkylation; Antineoplastic Agents; Antioxidants; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Glyceraldehyde-3-Phosphate Dehydrogenases; Glycolysis; HCT116 Cells; Humans; MCF-7 Cells; Monocarboxylic Acid Transporters; Monoterpenes; Necrosis; Neoplasms; Pyruvates; RNA Interference; Signal Transduction; Symporters; Transfection | 2017 |
In Vivo Anti-Tumor Activity and Toxicological Evaluations of Perillaldehyde 8,9-Epoxide, a Derivative of Perillyl Alcohol.
Topics: Animals; Antineoplastic Agents; Female; Fluorouracil; Mice; Monoterpenes; Neoplasm Transplantation; Neoplasms | 2016 |
Perillyl alcohol and genistein differentially regulate PKB/Akt and 4E-BP1 phosphorylation as well as eIF4E/eIF4G interactions in human tumor cells.
Topics: Adaptor Proteins, Signal Transducing; Cell Cycle Proteins; Cell Line, Tumor; Dose-Response Relationship, Drug; Eukaryotic Initiation Factor-4E; Eukaryotic Initiation Factor-4G; Gene Expression Regulation, Neoplastic; Genistein; Humans; Monoterpenes; Neoplasms; Phosphoproteins; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction | 2007 |
Modulation of RAS expression in human malignant cells by dietary supplements.
Topics: Antineoplastic Agents; Cyclohexenes; Dietary Supplements; Fatty Acids, Omega-3; Garlic; Gene Expression Regulation, Neoplastic; Genes, ras; Humans; Limonene; Monoterpenes; Neoplasms; Plants, Medicinal; Tea; Terpenes | 1997 |